K252169

Substantially Equivalent

Access BNP II

Applicant: Beckman Coulter, Inc.
Product code: NBC
Advisory panel: Clinical Chemistry
Date received: 2025-07-10
Decision date: 2026-03-24
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Chaska, MN, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.